California STI Treatment Recommendations in Pregnancy
These treatment regimens reflect the U.S. Centers for Disease Control and Prevention (CDC) STI Treatment Guidelines that are specific to pregnant people.
Service: Clinical
California STI/HIV Screening Recommendations in Pregnancy
Reflecting California HIV/STI screening recommendations for pregnant patients at various pregnancy stages.
STI Clinical Update Webinar: Dermatologic Manifestations of STIs
May 27, 2022
Presented by Ken Katz, MD
What you see is what they’ve got! Come learn about mucocutaneous signs and symptoms of sexually transmitted infections.
Learning Objectives
- Evaluate mucocutaneous manifestations of STIs.
- Apply knowledge about mucocutaneous manifestations of STIs to diagnosis and management of patients.
STI Expert Hour Webinar: Herpes Simplex Virus Infections – It’s Complicated
May 2, 2022
Presented by: Christine Johnston, MD, MPH, FIDSA and Terri Warren, BA, BSN, MEd, MSN
This webinar will focus on understanding the complex situation with herpes diagnostics—who to test, when to test, how to interpret tests, and how to obtain better tests. We will also discuss developments in new treatments and prevention methods and briefly touch on herpes counseling.
Learning Objectives:
- Participants will be able to discuss the limitations of currently available serologic diagnostic testing and how to optimize testing using a patient-centered approach.
- Participants will understand the current landscape of new and current HSV therapeutics.
- Participants will be able to state five key messages that should be included in counseling patients with a new or existing diagnosis of genital herpes.
PrEP Financing Resources
Resources and updates from the CAPTC’s PrEP Financing Learning Collaborative to support clinics and navigators with PrEP financing questions.
Includes information on California’s PrEP Assistance Program (PrEP-AP), other resources for covering the cost of PrEP, billing resources, and other coverage information for patients and providers.
Opt-Out ED Screening for HIV, HCV, and Syphilis—Dear Colleague Letter from CDPH
March 28, 2022: Emergency departments (EDs) are uniquely positioned to identify people with syphilis, HIV, and hepatitis C who otherwise might remain undiagnosed. The California Department of Public Health (CDPH) recommends that EDs consider implementing routine opt-out testing for syphilis, HIV, and hepatitis C.
Identification and immediate treatment through the ED may have the added benefit of furthering health equity for those disproportionately affected by these infections
STI Expert Hour Webinar: Addressing Systemic Racism in Sexual Health Settings
February 10, 2022
Presented by Leo Moore, MD, MSHPM
Social determinants of health grounded in racism may contribute to adverse sexual and reproductive health outcomes. This webinar will discuss some of the systemic and individual-level influences on the sexual health care experience that can result in medical mistrust. We will also discuss opportunities and provide evidence-based recommendations to promote health equity in sexual health care for patients from communities of color.
Learning objectives
- Describe two social determinants of health that may be affected by systemic racism.
- Discuss at least one intervention that can be implemented to improve health equity in sexual health care settings.
STI Expert Hour Webinar: Why the Dose Matters: PrEP Strategies for HIV
January 11, 2022
Presented by Katherine Yang, PharmD, MPH
Pre-Exposure prophylaxis (PrEP) has been shown to be safe and effective in reducing HIV infection. With recent updates in PrEP, many options are available, and selection of the best regimen is the key to success. The purpose of this webinar is to review the pharmacologic basis for drug dosing and outline gaps and challenges in management.
Learning objectives
- Review the key pharmacokinetic and pharmacodynamic properties of emtricitabine/tenofovir disoproxil fumarate, emtricitabine/tenofovir alafenamide, and cabotegravir.
- Identify patients who may be appropriate for Daily vs. Event-Driven PrEP.
- Review key side effects of PrEP and potential strategies for management.
- Describe the role of adherence on PrEP effectiveness.
STI Clinical Update Webinar: Congenital Syphilis Update for California Emergency Department Clinicians
December 14, 2021
Presented by Drs. Rosalyn Plotzker and Kristopher Lyon
The California Department of Public Health (CDPH) continues to see dramatic statewide increases in congenital syphilis (CS), a severe yet preventable condition when syphilis is passed from mother to fetus. In California, many infants with CS are born to parents who received care in an emergency department (ED) during pregnancy, suggesting syphilis screening in EDs may offer an important opportunity to detect syphilis in pregnancy and prevent CS.
This webinar features Dr. Rosalyn Plotzker, CDPH public health medical officer and co-author of the CDPH Expanded Syphilis Screening Recommendations for the Prevention of Congenital Syphilis. She will provide a clinical overview of CS prevention and discuss the recommendation to confirm syphilis status for pregnant patients in the ED. In addition, Dr. Kristopher Lyon, Public Health Officer and EMS medical director in Kern County, California and emergency department associate medical director, will present on syphilis screening in EDs from an on-the-ground perspective.
Learning Objectives
- Describe California’s congenital syphilis epidemiology
- Discuss the pathophysiology and management of syphilis, including among pregnant patients
- Explain and apply the CDPH recommendation to confirm syphilis status among pregnant patients receiving care in emergency departments
2021 CDC STI Treatment Guidelines Update: What’s New
December 10, 2021
Presented by Drs. Sharon Adler and Kelly Johnson
Learn more about the 2021 CDC STI Treatment Guidelines. Updated every 4-5 years, CDC’s STI Treatment Guidelines provide current evidence-based diagnostic, management, and treatment recommendations, and serve as a source of clinical guidance for managing sexually transmitted infections (STIs). This webinar will cover 2021 changes.
Learning Objectives
- Learn about and become proficient with the treatment updates
- Discuss and be able to share the rationale for the updates
- Understand the changes needed and apply them to clinical practice